|
291 |
Formulation Selection and Pharmacokinetic Comparison of Fentanyl Buccal Soluble Film with Oral Transmucosal Fentanyl Citrate
Enthalten in Clinical drug investigation Bd. 29, 17.9.2012, Nr. 10, date:10.2009: 647-654
|
|
|
|
292 |
Formulations of Fentanyl for the Management of Pain
Enthalten in Drugs Bd. 70, 17.9.2012, Nr. 1, date:1.2010: 57-72
|
|
|
|
293 |
Gabapentin Extended-Release Tablets for the Treatment of Patients with Postherpetic Neuralgia
Enthalten in Clinical drug investigation Bd. 30, 24.8.2012, Nr. 11, date:11.2010: 765-776
|
|
|
|
294 |
Generating Evidence for Comparative Effectiveness Research Using More Pragmatic Randomized Controlled Trials
Enthalten in PharmacoEconomics Bd. 28, 18.10.2012, Nr. 10, date:10.2010: 969-976
|
|
|
|
295 |
Genetic Influences in Sport and Physical Performance
Enthalten in Sports medicine Bd. 41, 7.10.2012, Nr. 10, date:10.2011: 845-859
|
|
|
|
296 |
Glatiramer Acetate
Enthalten in Drugs Bd. 70, 19.9.2012, Nr. 12, date:8.2010: 1545-1577
|
|
|
|
297 |
Global spending on orphan drugs in France, Germany, the UK, Italy and Spain during 2007
Enthalten in Applied health economics and health policy Bd. 8, 6.8.2012, Nr. 5, date:9.2010: 301-315
|
|
|
|
298 |
Glycosylation of Therapeutic Proteins
Enthalten in BioDrugs Bd. 24, 16.8.2012, Nr. 1, date:2.2010: 9-21
|
|
|
|
299 |
Health Economic and Infectious Disease Modelling
Enthalten in PharmacoEconomics Bd. 29, 23.12.2012, Nr. 5, date:5.2011: 367-369
|
|
|
|
300 |
Healthcare Costs and Obesity Prevention
Enthalten in PharmacoEconomics Bd. 27, 17.9.2012, Nr. 12, date:12.2009: 1031-1044
|
|
Administration
